Drug switching in the Netherlands: a cohort study of 20 active substances

by Pieter J. Glerum, Marc Maliepaard, Vincent de Valk, David M. Burger, Kees Neef
Published 2020-07-01

The Observed Effect of Gastric Bypass Surgery on Direct-acting Antiviral Treatment: a Case Report

by Elise J. Smolders, Sophie B. Willemse, Omar El-Sherif, Saye Khoo, David M. Burger
Published 2018-05-01

A population pharmacokinetics analysis assessing the exposure of raltegravir once‐daily 1200 mg in pregnant women living with HIV

by Vera E. Bukkems, Teun M. Post, Angela P. Colbers, David M. Burger, Elin M. Svensson
Published 2021-02-01

Rhabdomyolysis in a hepatitis C virus infected patient treated with telaprevir and simvastatin

by Clara T.M.M. de Kanter, Matthijs van Luin, Caroline Solas, David M. Burger, Jan Maarten Vrolijk
Published 2014-07-01

Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infection.

by Kay Seden, Sara Gibbons, Catia Marzolini, Jonathan M Schapiro, David M Burger, David J Back, Saye H Khoo
Published 2017-01-01

Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai children

by Torsak Bunupuradah, Passorn Punyahotra, Tim R. Cressey, Amornrat Srimuan, Narukjaporn Thammajaruk, Jiratchaya Sophonphan, Chulalak Sriheara, David M. Burger, Thanyawee Puthanakit, Jintanat Ananworanich
Published 2015-07-01

Efficacy and safety of a once-daily single-tablet regimen of tenofovir, lamivudine, and efavirenz assessed at 144 weeks among antiretroviral-naïve and experienced HIV-1-infected Th...

by Anchalee Avihingsanon, Wirach Maek-a-nantawat, Sivaporn Gatechompol, Vorapot Sapsirisavat, Wanida Thiansanguankul, Jiratchaya Sophonphan, Narujakorn Thammajaruk, Sasiwimol Ubolyam, David M. Burger, Kiat Ruxrungtham
Published 2017-08-01

Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands

by Pieter J. Glerum, Marc Maliepaard, Vincent deValk, Joep H.G. Scholl, Florence P.A.M. vanHunsel, Eugène P. vanPuijenbroek, David M. Burger, Kees Neef
Published 2020-05-01

Practical recommendations to combine small-molecule inhibitors and direct oral anticoagulants in patients with nonsmall cell lung cancer

by Leila S. Otten, Berber Piet, Michel M. van den Heuvel, Catia Marzolini, Robin M.J.M. van Geel, Judith L. Gulikers, David M. Burger, Jenneke Leentjens, Rob ter Heine
Published 2022-06-01

Lamivudine and Emtricitabine Dosing Proposal for Children with HIV and Chronic Kidney Disease, Supported by Physiologically Based Pharmacokinetic Modelling

by Tom G. Jacobs, Marika A. de Hoop-Sommen, Thomas Nieuwenstein, Joyce E. M. van der Heijden, Saskia N. de Wildt, David M. Burger, Angela Colbers, Jolien J. M. Freriksen
Published 2023-05-01

Pharmacokinetics and pharmacodynamics of azithromycin in severe malaria bacterial co-infection in African children (TABS-PKPD): a protocol for a Phase II randomised controlled tria...

by Sophie Uyoga, William Okiror, Diana M Gibb, Peter Olupot-Olupot, Rita Muhindo, Elizabeth C George, Kathryn Maitland, Thomas N Williams, David M Burger, Rob terHeine, Roisin Connon, Britta Urban, A Sarah Walker, Hellen Mnjalla, Ayub Mpoya
Published 2023-01-01

The Effect of β-Carotene Supplementation on the Pharmacokinetics of Nelfinavir and Its Active Metabolite M8 in HIV-1-infected Patients

by Humayoun Akhtar, Neera Singhal, Isabelle Seguin, Lina DelBalso, Marc Bourbeau, Bobby M. Chauhan, Donald William Cameron, Mohammed-Rachid Boulassel, David M. Burger, Richard G. Lalonde, Nancy L. Sheehan, Rolf P. G. van Heeswijk, Brian C. Foster
Published 2012-01-01

Ultra-fast analysis of plasma and intracellular levels of HIV protease inhibitors in children: a clinical application of MALDI mass spectrometry.

by Jeroen J A van Kampen, Mariska L Reedijk, Peter C Burgers, Lennard J M Dekker, Nico G Hartwig, Ineke E van der Ende, Ronald de Groot, Albert D M E Osterhaus, David M Burger, Theo M Luider, Rob A Gruters
Published 2010-01-01

Correction: Ultra-Fast Analysis of Plasma and Intracellular Levels of HIV Protease Inhibitors in Children: A Clinical Application of MALDI Mass Spectrometry.

by Jeroen J. A. van Kampen, Mariska L. Reedijk, Peter C. Burgers, Lennard J. M. Dekker, Nico G. Hartwig, Ineke E. van der Ende, Ronald de Groot, Albert D. M. E. Osterhaus, David M. Burger, Theo M. Luider, Rob A. Gruters
Published 2010-01-01

HIV-1 resistance against dolutegravir fluctuates rapidly alongside erratic treatment adherence: a case report

by Jeroen J.A. van Kampen, Hanh Thi Pham, Sunbin Yoo, Ronald J. Overmars, Cynthia Lungu, Rizwan Mahmud, Carolina A.M. Schurink, Sander van Boheemen, Rob A. Gruters, Pieter L.A. Fraaij, David M. Burger, Jolanda J.C. Voermans, Casper Rokx, David A.M.C. van de Vijver, Thibault Mesplède
Published 2022-12-01

ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested phar...

by Cecilia L. Moore, Anna Turkova, Hilda Mujuru, Adeodata Kekitiinwa, Abbas Lugemwa, Cissy M. Kityo, Linda N. Barlow-Mosha, Tim R. Cressey, Avy Violari, Ebrahim Variava, Mark F. Cotton, Moherndran Archary, Alexandra Compagnucci, Thanyawee Puthanakit, Osee Behuhuma, Yacine Saϊdi, James Hakim, Pauline Amuge, Lorna Atwine, Victor Musiime, David M. Burger, Clare Shakeshaft, Carlo Giaquinto, Pablo Rojo, Diana M. Gibb, Deborah Ford, the ODYSSEY Trial Team
Published 2021-01-01